Latest Conmed Corp (CNMD) Headlines CONMED Corp
Post# of 27
Posted On: 03/12/2014 7:31:51 PM
Latest Conmed Corp (CNMD) Headlines
CONMED Corporation Highlights New Products at the 2014 Annual American Academy of Orthopaedic Surgeons Meeting
Marketwire - Tue Mar 11, 6:01AM CDT
CONMED Corporation (NASDAQ: CNMD) today announced the launch of a new line of products that will be showcased at this year's American Academy of Orthopaedic Surgeons Annual Meeting in New Orleans. The new products, available at exhibit booth #2249, include recent additions to the Y-Knot(R) all-suture anchor line, a new offering for Hall(R) battery operated power instruments as well as the latest in High Definition advanced surgical visualization.
Concise Analysis of the International Enteral Feeding Devices Market
M2 - Fri Mar 07, 5:54AM CST
Research and Markets (http://www.researchandmarkets.com/research/ldl6z9/enteral_feeding) has announced the addition of the "Concise Analysis of the International Enteral Feeding Devices Market" report to their offering. This report analyzes the worldwide markets for Enteral Feeding Devices in US$ Million by the following Product Categories: Enteral Feeding Pumps, Nasogastric Tubes, and Others. The report provides separate comprehensive analytics for the US Canada, Japan, Europe, Asia-Pacific, Latin America, and Rest of World. Annual estimates and forecasts are provided for the period 2010 through 2018. Also, a six-year historic analysis is provided for these markets. The report profiles 38 companies including many key and niche players such as: - American HomePatient, Inc. - Amsino International, Inc. - Applied Medical Technology, Inc. - Boston Scientific Corporation - C. R. Bard, Inc. - Caesarea Medical Electronics Ltd. - Cook Medical, Inc. - CONMED Corporation - CORPAK MedSystems, Inc. - Covidien Plc - Fresenius SE & Co. KGaA - Fresenius KABI AG - Kimberly-Clark Corporation - Moog Inc. - Nestl? HealthCare Nutrition - Nutricia Advanced Medical Nutrition - VYGON SA Market data and analytics are derived from primary and secondary research. Company profiles are primarily based on public domain information including company URLs. Please note: Reports are sold as single-site single-user licenses. Electronic versions require 24-48 hours as each copy is customized to the client with digital controls and custom watermarks. For information on site licence pricing please click on Enquire before buying. Key Topics Covered: I. Introduction, Methodology & Product Definitions II. Executive Summary 1. Industry Overview 2. Market Drivers, Trends & Issues 3. Product Overview 4. Recent Product Innovations/ Launches 5. Recent Industry Activity 6. Focus On Select Global Players 7. Global Market Perspective III. Market 1. The United States 2. Canada 3. Japan 4. Europe 5. Asia-Pacific 6. Latin America 7. Rest Of World IV. Competitive Landscape Total Companies Profiled: 38 (including Divisions/Subsidiaries - 52) - The United States (24) - Canada (1) - Europe (20) - France (3) - Germany (5) - The United Kingdom (6) - Rest of Europe (6) - Asia-Pacific (Excluding Japan) (6) - Middle East (1) For more information visit http://www.researchandmarkets.com/research/ld...al_feeding
CONMED Corporation to Present at the 2014 Canaccord Genuity Musculoskeletal Conference
Marketwire - Wed Mar 05, 6:01AM CST
CONMED Corporation (NASDAQ: CNMD), a medical technology company specializing in medical devices for orthopedic and general surgery markets, announced today that the Company will participate in the 2014 Canaccord Genuity Musculoskeletal Conference on Tuesday, March 11, 2014 at 10:50 AM Central time. The event will be held in New Orleans at the Sheraton New Orleans Hotel.
CONMED Corporation Sets Annual Meeting Date
Marketwire - Fri Feb 28, 6:00AM CST
CONMED Corporation (NASDAQ: CNMD) announced today that its Annual Meeting of Shareholders will be held at the Company's corporate offices, 525 French Road, Utica, NY 13502 on Thursday, May 22, 2014 at 3:30 P.M. Eastern Time. Shareholders of record at the close of business on April 3, 2014 shall be entitled to vote at the 2014 Annual Meeting.
Voce Capital Responds to ConMed Board Changes
Business Wire - Thu Feb 27, 4:16PM CST
--Voce's Independent Nominees Offer Shareholders Ability to Choose Best Combination of Directors
CONMED Corporation Announces Quarterly Cash Dividend
Marketwire - Thu Feb 27, 3:30PM CST
CONMED Corporation (NASDAQ: CNMD) announced today that its Board of Directors has declared a quarterly cash dividend of $0.20 per share, payable on April 7, 2014 to all shareholders of record as of March 17, 2014. The Board expects that future cash dividends will be paid on a quarterly basis such that the total annual dividend rate based on the quarterly cash dividend will equal $0.80 per share, which is equivalent to a dividend yield of approximately 1.7% at current share prices. Any decision to pay future cash dividends will, however, be subject to Board approval, and will depend on the Company's future earnings, cash flow, financial condition, financial covenants, and other relevant factors.
CONMED Corporation Announces Board and Governance Changes
Marketwire - Tue Feb 25, 5:30PM CST
CONMED Corporation (NASDAQ: CNMD)
Global Arthroscopy Devices Market 2014-2018: CAGR, Market Size, Forecasts till 2018
M2 - Thu Feb 20, 11:02AM CST
Research and Markets (http://www.researchandmarkets.com/research/dbrhvh/global) has announced the addition of the "Global Arthroscopy Devices Market 2014-2018" report to their offering. The analysts forecast the Global Arthroscopy Devices market 2014-2018 to grow at a CAGR of 6.22 percent over the period 2013-2018. One of the key factors contributing to this market growth is the increasing aging population. The Global Arthroscopy Devices market has also been witnessing the increasing small-joint and hip arthroscopy procedure volumes. However, the lack of reimbursement benefits could pose a challenge to the growth of this market. Key vendors dominating this space include Arthrex Inc., CONMED Corp., Johnson & Johnson and Smith & Nephew plc. Other vendors mentioned in the report are ArthroCare Corp., Biomet Inc., KARL STORZ GmbH & Co. KG, Olympus Corp., StryKer Corp. and Richard Wolf Medical Instruments Corp. Commenting on the report, an analyst from the team said: There has been an increase in the small-joint and hip arthroscopy procedure volumes over the past decade. There has been an increasing number of trained physicians that perform hip arthroscopy for the diagnosis and treatment of hip pain as well as the removal of loose bodies in the hip joint. The reduction in the dimensions of arthroscopic devices and the improvement in understanding the internal anatomy of small joints have led to arthroscopically evaluating and treating various disorders. Certain companies such as ArthroCare, ConMed, Smith & Nephew, and Stryker have developed specialized devices for hip arthroscopy that include extended-length arthroscopes, radio frequency probes, and power shaver blades. According to the report, one of the main drivers in this market is the increasing aging population. The increasing prevalence of musculoskeletal disorders and joint injuries in the rising aged population has increased the demand for arthroscopy devices for the early diagnosis of joint disorders. For more information visit http://www.researchandmarkets.com/research/dbrhvh/global About Research and Markets Research and Markets is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
CONMED Q4 Earnings Beat Ests, Up Marginally - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Fri Feb 14, 12:30PM CST
For full year 2013, adjusted net earnings fell 1.7% to $50.8 million from $51.7 million a year ago but earnings per share rose 0.6% to $1.81 from $1.80 in 2012.
What It's Like Researching Rape in Somalia [interview]
All Africa Global Media - Fri Feb 14, 4:10AM CST
Samer Muscati, who researches the plight of women in conflict and emergency situations, recently spent time in one of the world's most dangerous cities: Mogadishu, Somalia. There, he was part of a team that interviewed more than two dozen rape victims for a report, "Here, Rape is Normal". Muscati talks to us about women in Somalia, how rape is a horrible symptom of a greater problem, and ways to advocate with a government in a war-torn country that can barely exercise control over its capital city.
/ CORRECTION - CONMED Corporation Fourth Quarter 2013 Financial Results Exceed Company Guidance
Marketwire - Thu Feb 13, 8:52AM CST
In the news release, "CONMED Corporation Fourth Quarter 2013 Financial Results Exceed Company Guidance," issued earlier today by CONMED Corporation (NASDAQ: CNMD), please be advised that the table headings "Twelve months ended December 31" and "Three months ended December 31" should have been switched for tables RECONCILIATION OF INCOME FROM OPERATIONS TO ADJUSTED INCOME FROM OPERATIONS and RECONCILIATION OF REPORTED NET INCOME TO EBITDA & ADJUSTED EBITDA. Complete corrected text follows.
CONMED Corporation Fourth Quarter 2013 Financial Results Exceed Company Guidance
Marketwire - Thu Feb 13, 6:00AM CST
CONMED Corporation (NASDAQ: CNMD)
CONMED Corporation Comments on Voce Capital Press Release
Marketwire - Tue Feb 11, 12:14PM CST
CONMED Corporation (NASDAQ: CNMD) today issued a statement in response to a press release issued by Voce Capital Management LLC, which reportedly owns less than 1% of the outstanding shares of CONMED, announcing its nomination of four director candidates to stand for election to the CONMED Board of Directors at the Company's 2014 Annual Meeting of Stockholders. CONMED shareholders are not required to take any action at this time.
Voce Capital Commences Proxy Contest at ConMed
Business Wire - Tue Feb 11, 8:00AM CST
Voce Capital Management LLC ("Voce") announces its nomination of four independent directors for election to the Board of Directors of CONMED Corporation ("ConMed" or the "Company") (Nasdaq:CNMD) at the Company's 2014 annual meeting.
CONMED Corporation to Announce Fourth Quarter 2013 Financial Results on February 13, 2014
Marketwire - Mon Jan 13, 6:00AM CST
CONMED Corporation (NASDAQ: CNMD) announced today that it expects to report fourth quarter 2013 financial results before the market opens on Thursday, February 13, 2014, and will also hold a conference call live over the Internet at 10:00 a.m. Eastern Time that same day. This webcast can be accessed from CONMED's web site at www.conmed.com. Replays of the call will be made available through February 21, 2014.
CONMED Corporation to Present at the 16th Annual Needham Growth Conference
Marketwire - Wed Jan 08, 6:00AM CST
CONMED Corporation (NASDAQ: CNMD), a medical technology company specializing in medical devices for surgical markets, announced today that the Company will participate in the 16th Annual Needham Growth Conference, on Wednesday, January 15, 2014 at 9:20 AM Eastern time. The event will be held in New York at the New York Palace Hotel.
5 Stocks Breaking Out on Big Volume
at The Street - Tue Dec 31, 8:58AM CST
These stocks trading on unusual volume are within range of triggering breakout trades.
Conmed Up 19.5% Since SmarTrend Uptrend Call (CNMD)
Comtex SmarTrend(R) - Mon Dec 09, 9:33AM CST
SmarTrend identified an Uptrend for Conmed (NASDAQ:CNMD) on September 10th, 2013 at $33.40. In approximately 3 months, Conmed has returned 19.46% as of today's recent price of $39.90.
Uptrend Call Working As Conmed Stock Rises 23.1% (CNMD)
Comtex SmarTrend(R) - Mon Dec 02, 9:27AM CST
SmarTrend identified an Uptrend for Conmed (NASDAQ:CNMD) on September 10th, 2013 at $33.40. In approximately 3 months, Conmed has returned 23.08% as of today's recent price of $41.11.
CONMED Retained at Neutral - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Tue Nov 26, 2:20PM CST
We have reiterated our recommendation for CONMED at Neutral.
CONMED Corporation Highlights New Products at the 2014 Annual American Academy of Orthopaedic Surgeons Meeting
Marketwire - Tue Mar 11, 6:01AM CDT
CONMED Corporation (NASDAQ: CNMD) today announced the launch of a new line of products that will be showcased at this year's American Academy of Orthopaedic Surgeons Annual Meeting in New Orleans. The new products, available at exhibit booth #2249, include recent additions to the Y-Knot(R) all-suture anchor line, a new offering for Hall(R) battery operated power instruments as well as the latest in High Definition advanced surgical visualization.
Concise Analysis of the International Enteral Feeding Devices Market
M2 - Fri Mar 07, 5:54AM CST
Research and Markets (http://www.researchandmarkets.com/research/ldl6z9/enteral_feeding) has announced the addition of the "Concise Analysis of the International Enteral Feeding Devices Market" report to their offering. This report analyzes the worldwide markets for Enteral Feeding Devices in US$ Million by the following Product Categories: Enteral Feeding Pumps, Nasogastric Tubes, and Others. The report provides separate comprehensive analytics for the US Canada, Japan, Europe, Asia-Pacific, Latin America, and Rest of World. Annual estimates and forecasts are provided for the period 2010 through 2018. Also, a six-year historic analysis is provided for these markets. The report profiles 38 companies including many key and niche players such as: - American HomePatient, Inc. - Amsino International, Inc. - Applied Medical Technology, Inc. - Boston Scientific Corporation - C. R. Bard, Inc. - Caesarea Medical Electronics Ltd. - Cook Medical, Inc. - CONMED Corporation - CORPAK MedSystems, Inc. - Covidien Plc - Fresenius SE & Co. KGaA - Fresenius KABI AG - Kimberly-Clark Corporation - Moog Inc. - Nestl? HealthCare Nutrition - Nutricia Advanced Medical Nutrition - VYGON SA Market data and analytics are derived from primary and secondary research. Company profiles are primarily based on public domain information including company URLs. Please note: Reports are sold as single-site single-user licenses. Electronic versions require 24-48 hours as each copy is customized to the client with digital controls and custom watermarks. For information on site licence pricing please click on Enquire before buying. Key Topics Covered: I. Introduction, Methodology & Product Definitions II. Executive Summary 1. Industry Overview 2. Market Drivers, Trends & Issues 3. Product Overview 4. Recent Product Innovations/ Launches 5. Recent Industry Activity 6. Focus On Select Global Players 7. Global Market Perspective III. Market 1. The United States 2. Canada 3. Japan 4. Europe 5. Asia-Pacific 6. Latin America 7. Rest Of World IV. Competitive Landscape Total Companies Profiled: 38 (including Divisions/Subsidiaries - 52) - The United States (24) - Canada (1) - Europe (20) - France (3) - Germany (5) - The United Kingdom (6) - Rest of Europe (6) - Asia-Pacific (Excluding Japan) (6) - Middle East (1) For more information visit http://www.researchandmarkets.com/research/ld...al_feeding
CONMED Corporation to Present at the 2014 Canaccord Genuity Musculoskeletal Conference
Marketwire - Wed Mar 05, 6:01AM CST
CONMED Corporation (NASDAQ: CNMD), a medical technology company specializing in medical devices for orthopedic and general surgery markets, announced today that the Company will participate in the 2014 Canaccord Genuity Musculoskeletal Conference on Tuesday, March 11, 2014 at 10:50 AM Central time. The event will be held in New Orleans at the Sheraton New Orleans Hotel.
CONMED Corporation Sets Annual Meeting Date
Marketwire - Fri Feb 28, 6:00AM CST
CONMED Corporation (NASDAQ: CNMD) announced today that its Annual Meeting of Shareholders will be held at the Company's corporate offices, 525 French Road, Utica, NY 13502 on Thursday, May 22, 2014 at 3:30 P.M. Eastern Time. Shareholders of record at the close of business on April 3, 2014 shall be entitled to vote at the 2014 Annual Meeting.
Voce Capital Responds to ConMed Board Changes
Business Wire - Thu Feb 27, 4:16PM CST
--Voce's Independent Nominees Offer Shareholders Ability to Choose Best Combination of Directors
CONMED Corporation Announces Quarterly Cash Dividend
Marketwire - Thu Feb 27, 3:30PM CST
CONMED Corporation (NASDAQ: CNMD) announced today that its Board of Directors has declared a quarterly cash dividend of $0.20 per share, payable on April 7, 2014 to all shareholders of record as of March 17, 2014. The Board expects that future cash dividends will be paid on a quarterly basis such that the total annual dividend rate based on the quarterly cash dividend will equal $0.80 per share, which is equivalent to a dividend yield of approximately 1.7% at current share prices. Any decision to pay future cash dividends will, however, be subject to Board approval, and will depend on the Company's future earnings, cash flow, financial condition, financial covenants, and other relevant factors.
CONMED Corporation Announces Board and Governance Changes
Marketwire - Tue Feb 25, 5:30PM CST
CONMED Corporation (NASDAQ: CNMD)
Global Arthroscopy Devices Market 2014-2018: CAGR, Market Size, Forecasts till 2018
M2 - Thu Feb 20, 11:02AM CST
Research and Markets (http://www.researchandmarkets.com/research/dbrhvh/global) has announced the addition of the "Global Arthroscopy Devices Market 2014-2018" report to their offering. The analysts forecast the Global Arthroscopy Devices market 2014-2018 to grow at a CAGR of 6.22 percent over the period 2013-2018. One of the key factors contributing to this market growth is the increasing aging population. The Global Arthroscopy Devices market has also been witnessing the increasing small-joint and hip arthroscopy procedure volumes. However, the lack of reimbursement benefits could pose a challenge to the growth of this market. Key vendors dominating this space include Arthrex Inc., CONMED Corp., Johnson & Johnson and Smith & Nephew plc. Other vendors mentioned in the report are ArthroCare Corp., Biomet Inc., KARL STORZ GmbH & Co. KG, Olympus Corp., StryKer Corp. and Richard Wolf Medical Instruments Corp. Commenting on the report, an analyst from the team said: There has been an increase in the small-joint and hip arthroscopy procedure volumes over the past decade. There has been an increasing number of trained physicians that perform hip arthroscopy for the diagnosis and treatment of hip pain as well as the removal of loose bodies in the hip joint. The reduction in the dimensions of arthroscopic devices and the improvement in understanding the internal anatomy of small joints have led to arthroscopically evaluating and treating various disorders. Certain companies such as ArthroCare, ConMed, Smith & Nephew, and Stryker have developed specialized devices for hip arthroscopy that include extended-length arthroscopes, radio frequency probes, and power shaver blades. According to the report, one of the main drivers in this market is the increasing aging population. The increasing prevalence of musculoskeletal disorders and joint injuries in the rising aged population has increased the demand for arthroscopy devices for the early diagnosis of joint disorders. For more information visit http://www.researchandmarkets.com/research/dbrhvh/global About Research and Markets Research and Markets is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
CONMED Q4 Earnings Beat Ests, Up Marginally - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Fri Feb 14, 12:30PM CST
For full year 2013, adjusted net earnings fell 1.7% to $50.8 million from $51.7 million a year ago but earnings per share rose 0.6% to $1.81 from $1.80 in 2012.
What It's Like Researching Rape in Somalia [interview]
All Africa Global Media - Fri Feb 14, 4:10AM CST
Samer Muscati, who researches the plight of women in conflict and emergency situations, recently spent time in one of the world's most dangerous cities: Mogadishu, Somalia. There, he was part of a team that interviewed more than two dozen rape victims for a report, "Here, Rape is Normal". Muscati talks to us about women in Somalia, how rape is a horrible symptom of a greater problem, and ways to advocate with a government in a war-torn country that can barely exercise control over its capital city.
/ CORRECTION - CONMED Corporation Fourth Quarter 2013 Financial Results Exceed Company Guidance
Marketwire - Thu Feb 13, 8:52AM CST
In the news release, "CONMED Corporation Fourth Quarter 2013 Financial Results Exceed Company Guidance," issued earlier today by CONMED Corporation (NASDAQ: CNMD), please be advised that the table headings "Twelve months ended December 31" and "Three months ended December 31" should have been switched for tables RECONCILIATION OF INCOME FROM OPERATIONS TO ADJUSTED INCOME FROM OPERATIONS and RECONCILIATION OF REPORTED NET INCOME TO EBITDA & ADJUSTED EBITDA. Complete corrected text follows.
CONMED Corporation Fourth Quarter 2013 Financial Results Exceed Company Guidance
Marketwire - Thu Feb 13, 6:00AM CST
CONMED Corporation (NASDAQ: CNMD)
CONMED Corporation Comments on Voce Capital Press Release
Marketwire - Tue Feb 11, 12:14PM CST
CONMED Corporation (NASDAQ: CNMD) today issued a statement in response to a press release issued by Voce Capital Management LLC, which reportedly owns less than 1% of the outstanding shares of CONMED, announcing its nomination of four director candidates to stand for election to the CONMED Board of Directors at the Company's 2014 Annual Meeting of Stockholders. CONMED shareholders are not required to take any action at this time.
Voce Capital Commences Proxy Contest at ConMed
Business Wire - Tue Feb 11, 8:00AM CST
Voce Capital Management LLC ("Voce") announces its nomination of four independent directors for election to the Board of Directors of CONMED Corporation ("ConMed" or the "Company") (Nasdaq:CNMD) at the Company's 2014 annual meeting.
CONMED Corporation to Announce Fourth Quarter 2013 Financial Results on February 13, 2014
Marketwire - Mon Jan 13, 6:00AM CST
CONMED Corporation (NASDAQ: CNMD) announced today that it expects to report fourth quarter 2013 financial results before the market opens on Thursday, February 13, 2014, and will also hold a conference call live over the Internet at 10:00 a.m. Eastern Time that same day. This webcast can be accessed from CONMED's web site at www.conmed.com. Replays of the call will be made available through February 21, 2014.
CONMED Corporation to Present at the 16th Annual Needham Growth Conference
Marketwire - Wed Jan 08, 6:00AM CST
CONMED Corporation (NASDAQ: CNMD), a medical technology company specializing in medical devices for surgical markets, announced today that the Company will participate in the 16th Annual Needham Growth Conference, on Wednesday, January 15, 2014 at 9:20 AM Eastern time. The event will be held in New York at the New York Palace Hotel.
5 Stocks Breaking Out on Big Volume
at The Street - Tue Dec 31, 8:58AM CST
These stocks trading on unusual volume are within range of triggering breakout trades.
Conmed Up 19.5% Since SmarTrend Uptrend Call (CNMD)
Comtex SmarTrend(R) - Mon Dec 09, 9:33AM CST
SmarTrend identified an Uptrend for Conmed (NASDAQ:CNMD) on September 10th, 2013 at $33.40. In approximately 3 months, Conmed has returned 19.46% as of today's recent price of $39.90.
Uptrend Call Working As Conmed Stock Rises 23.1% (CNMD)
Comtex SmarTrend(R) - Mon Dec 02, 9:27AM CST
SmarTrend identified an Uptrend for Conmed (NASDAQ:CNMD) on September 10th, 2013 at $33.40. In approximately 3 months, Conmed has returned 23.08% as of today's recent price of $41.11.
CONMED Retained at Neutral - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Tue Nov 26, 2:20PM CST
We have reiterated our recommendation for CONMED at Neutral.
(0)
(0)Conmed Corp. (CNMD) Stock Research Links
Scroll down for more posts ▼